18
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Nesiritide for the treatment of decompensated heart failure

&
Pages 803-813 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kwadwo Osei Bonsu, Isaac Kofi Owusu, Kwame Ohene Buabeng, Daniel Diamond Reidpath & Amudha Kadirvelu. (2016) Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies. Therapeutics and Clinical Risk Management 12, pages 887-906.
Read now

Articles from other publishers (3)

A. Pol, M. F. Hoes, R. A. Boer & P. Meer. (2020) Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart. Journal of Internal Medicine 288:5, pages 491-506.
Crossref
Annette Vegas. (2008) Assisting the Failing Heart. Anesthesiology Clinics 26:3, pages 539-564.
Crossref
Tobias Gerhard, Issam Zineh, Almut G. Winterstein & Abraham G. Hartzema. (2012) Pharmacoeconomic Modeling of Nesiritide versus Dobutamine for Decompensated Heart Failure. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:1, pages 34-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.